Can Pregnant Women Take Levatol?
Levatol and Pregnancy Category C
The U.
S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
When Levatol was given to pregnant rabbits, an increased the risk of fetal death and newborn death was seen. However, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a woman if a healthcare provider believes that the benefits outweigh any possible risks to the unborn child.
With beta blockers in general, there have been reports of slowed intrauterine growth, small placentas, and birth defects related to the use of beta blockers during pregnancy. There have also been reports of a very low heart rate, low blood sugar, and/or decreased breathing in some newborns whose mothers took beta blockers just before or during childbirth.